Neurosense Therapeutics Ltd
neurosense-tx.comWhat Do They Do?
Develops experimental treatments for people with amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease, including PrimeC, a candidate designed to treat amyotrophic lateral sclerosis.
20-F for FY2025, filed Mar 31, 2026We are a clinical-stage biotechnology company focused on discovering and developing treatments for people living with neurodegenerative…View ↗
Our lead therapeutic candidate, PrimeC, is a novel extended-release oral formulation, fixed-dose combination of two FDA-approved drugs…View ↗
In addition to PrimeC, we extended our pipeline and conducted research and development efforts for AD and PD, with a similar strategy of…View ↗
How Do They Make Money?
No revenue reported yet.
20-F for FY2025, filed Mar 31, 2026
Who Do They Compete With?
Competes with Biogen, Novartis, AB Science, Prilenia Therapeutics, Brainstorm Cell Therapeutics, Clene, QurAlis, Eli Lilly, Eisai, Roche, Alector, Prothena, Prevail, AstraZeneca, and Takeda
20-F for FY2025, filed Mar 31, 2026ALS. Potentially disease modifying therapeutics are being developed by several large and specialty pharmaceutical and biotechnology…View ↗
Loading...
